Tetsuhiko Sato
Overview
Explore the profile of Tetsuhiko Sato including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koike M, Sato T, Shiozaki Y, Komiya A, Miura M, Higashi A, et al.
J Clin Biochem Nutr
. 2024 May;
74(3):221-229.
PMID: 38799134
Growth hormone (GH) exerts multiple effects on different organs directly or via its main mediator, insulin-like growth factor1 (IGF1). In this study, we focused on the novel relationship between GH...
2.
Okada M, Sato T, Himeno T, Hasegawa Y, Futamura K, Hiramitsu T, et al.
Transpl Int
. 2024 May;
37:12704.
PMID: 38751772
Tertiary hyperparathyroidism (THPT) is characterized by elevated parathyroid hormone and serum calcium levels after kidney transplantation (KTx). To ascertain whether pre-transplant calcimimetic use and dose information would improve THPT prediction...
3.
Okada M, Sato T, Hasegawa Y, Futamura K, Hiramitsu T, Ichimori T, et al.
Clin Exp Nephrol
. 2023 Jun;
27(10):882-889.
PMID: 37351681
Background: Long-term dialysis vintage is a predictor of persistent hyperparathyroidism (HPT) after kidney transplantation (KTx). Recently, preemptive kidney transplantation (PKT) has increased. However, the incidence, predictors, and clinical implications of...
4.
Sato T, Azuma Y, Ozone C, Okazaki M, Takeda A, Okada M, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(10):2597-2603.
PMID: 36974363
Context: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have the potential to improve native kidney function. Objective: This work aimed to elucidate the possible protective effects of GLP-1 RAs on kidney...
5.
Okada M, Tominaga Y, Sato T, Tomosugi T, Futamura K, Hiramitsu T, et al.
BMC Nephrol
. 2022 Jun;
23(1):212.
PMID: 35710357
Background: Hypercalcemic hyperparathyroidism has been associated with poor outcomes after kidney transplantation (KTx). However, the clinical implications of normocalcemic hyperparathyroidism after KTx are unclear. This retrospective cohort study attempted to...
6.
Okada M, Tominaga Y, Tomosugi T, Hiramitsu T, Ichimori T, Sato T
World J Surg
. 2021 Jun;
45(9):2777-2784.
PMID: 34132848
Background: Parathyroidectomy (PTx) reportedly increases bone mineral density (BMD) in patients with severe secondary hyperparathyroidism (SHPT). To date, however, there has not been sufficient evidence on predictors of BMD improvement...
7.
Sato T, Kikkawa Y, Yamamoto S, Tanaka Y, Kazama J, Tominaga Y, et al.
Clin Kidney J
. 2019 Oct;
12(5):686-692.
PMID: 31583093
Background: Parathyroidectomy (PTX) that alleviates clinical manifestations of advanced hyperparathyroidism, including hypercalcemia and hypophosphatemia, is considered the best protection from calcium overload in the kidney. However, little is known about...
8.
Okada M, Hiramitsu T, Ichimori T, Goto N, Narumi S, Watarai Y, et al.
World J Surg
. 2019 Aug;
44(2):498-507.
PMID: 31399797
Background: The effect of parathyroidectomy (PTx) timing on serum calcium (Ca) levels and renal functions in renal transplant recipients with severe hyperparathyroidism (HPT) remains unclear. We retrospectively aimed to investigate...
9.
Sato T, Otsuka Y, Kikkawa Y, Iwasaki Y, Fukagawa M
J Vasc Access
. 2019 Apr;
20(1_suppl):55-59.
PMID: 31032725
Vascular access failure, such as recurrent stenosis and thrombosis, is a major concern in patients with end-stage kidney disease. Neointimal hyperplasia development at the anastomosis site of outflow vessels is...
10.
Sato T, Komaba H, Nagatani T, Watanabe T, Kishida Y, Fukagawa M
J Endocr Soc
. 2019 Jan;
3(1):52-61.
PMID: 30697600
Context: The antiaging protein Klotho is shed and released into the blood stream (soluble Klotho). Growth hormone (GH) is considered an active Klotho regulator, because growth retardation is described in...